DeMarco, Joseph P <br/><br/>
Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial.  [electronic resource] 

 -  The American journal of bioethics : AJOB  2014 
 - 4-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-0075 
<br/><br/><label>Standard No.: </label>10.1080/15265161.2014.889240  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--metabolism<br/>Cardiovascular Diseases--blood<br/>Cause of Death<br/>Clinical Trials Data Monitoring Committees<br/>Clinical Trials as Topic--ethics<br/>Codes of Ethics<br/>Decision Making<br/>Drug Therapy, Combination<br/>Ethics Committees, Research<br/>Ethics, Research<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Informed Consent--ethics<br/>Metformin--administration & dosage<br/>Moral Obligations<br/>Mortality--trends<br/>Research Personnel--ethics<br/>Research Subjects<br/>Risk<br/>Sulfonylurea Compounds--administration & dosage<br/>Therapeutic Equipoise<br/>Truth Disclosure--ethics<br/>Uncertainty